Abbott Laboratories (ABT)

Long-Term Debt

$29.60B

Quarterly · Period ending: · USD

ABT logo

ABT Long-Term Debt

Latest reported$29.60B
ABT Quarterly Long-Term Debt ($443.00M → $29.60B)
High-resolution chart · PNG

ABT long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Long-Term Debt — Quarterly (USD)
Period endingLong-Term Debt (USD)
4,310,744,000
1,076,372,000
1,076,368,000
1,076,316,000
1,326,416,000
1,326,746,000
1,336,789,000
1,336,425,000
1,337,566,000
1,339,524,000
1,339,694,000
1,340,845,000
1,141,258,000
1,139,720,000
937,983,000
939,485,000
931,055,000
931,227,000
932,898,000
682,166,000
433,437,000
433,724,000
435,198,000
435,297,000
435,730,000
285,548,000
287,091,000
307,920,000
307,275,000
306,855,000
306,840,000
108,500,000
108,700,000
108,400,000
110,000,000
95,200,000
107,400,000
122,800,000
125,100,000
132,200,000
134,700,000
133,200,000
134,800,000
137,100,000
138,200,000
149,100,000
146,700,000
349,300,000
271,000,000
297,400,000
443,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.